Advertisement

Advertisement

MAIA Stock Latest News

MAIA Biotechnology opens third clinical site in U.S. for Phase 2 THIO-101 trial

The FlyMAIA Biotechnology opens third clinical site in U.S. for Phase 2 THIO-101 trial

MAIA Biotechnology reports 29 patients dosed in Phase 3 THIO-104 trial

PremiumThe Fly

MAIA Biotechnology reports 29 patients dosed in Phase 3 THIO-104 trial

1M ago

MAIA Biotechnology receives FDA clearance for amendment to IND application

PremiumThe Fly

MAIA Biotechnology receives FDA clearance for amendment to IND application

1M ago

MAIA Biotechnology announces open market purchases by CEO, director

PremiumThe Fly

MAIA Biotechnology announces open market purchases by CEO, director

1M ago

MAIA Biotechnology Shareholders Back Board and Auditor Appointments

PremiumCompany Announcements

MAIA Biotechnology Shareholders Back Board and Auditor Appointments

1M ago

MAIA Biotechnology Ends ATM Stock Offering Agreement

PremiumCompany AnnouncementsMAIA Biotechnology Ends ATM Stock Offering Agreement

2M ago

MAIA Expands THIO-101 Lung Cancer Trial in U.S.

Company Announcements

MAIA Expands THIO-101 Lung Cancer Trial in U.S.

3M ago

MAIA Fully Funds Pivotal Phase 3 THIO-104 NSCLC Trial

Company Announcements

MAIA Fully Funds Pivotal Phase 3 THIO-104 NSCLC Trial

3M ago

MAIA Biotechnology secures funding for clinical trial of ateganosine

PremiumThe Fly

MAIA Biotechnology secures funding for clinical trial of ateganosine

3M ago

MAIA Biotechnology Awards Executive Bonuses After Successful Financing

PremiumCompany Announcements

MAIA Biotechnology Awards Executive Bonuses After Successful Financing

3M ago

MAIA Highlights Promising Phase 2 NSCLC Survival Outcomes

PremiumCompany Announcements

MAIA Highlights Promising Phase 2 NSCLC Survival Outcomes

3M ago

MAIA Showcases THIO-101 NSCLC Data at ELCC 2026

PremiumCompany Announcements

MAIA Showcases THIO-101 NSCLC Data at ELCC 2026

3M ago

MAIA Biotechnology Completes $30 Million Public Stock Offering

PremiumCompany AnnouncementsMAIA Biotechnology Completes $30 Million Public Stock Offering

4M ago

MAIA Biotechnology 20M share Spot Secondary priced at $1.50

The Fly

MAIA Biotechnology 20M share Spot Secondary priced at $1.50

4M ago

MAIA Biotechnology announces common stock offering, no amount given

The Fly

MAIA Biotechnology announces common stock offering, no amount given

4M ago

MAIA Biotechnology Highlights Progress in Phase 3 Oncology Program

PremiumCompany Announcements

MAIA Biotechnology Highlights Progress in Phase 3 Oncology Program

4M ago

MAIA Biotechnology published a 2026 Letter to Shareholders

PremiumThe Fly

MAIA Biotechnology published a 2026 Letter to Shareholders

4M ago

MAIA Biotechnology outlines 2026 goals for ateganosine program

PremiumCompany Announcements

MAIA Biotechnology outlines 2026 goals for ateganosine program

6M ago

MAIA Biotechnology highlights milestones, catalysts for FY26

PremiumThe Fly

MAIA Biotechnology highlights milestones, catalysts for FY26

6M ago

MAIA Biotechnology Highlights Strategy in New Investor Presentation

PremiumCompany AnnouncementsMAIA Biotechnology Highlights Strategy in New Investor Presentation

6M ago

MAIA Biotechnology directors participate in private placement financings

The Fly

MAIA Biotechnology directors participate in private placement financings

6M ago

MAIA Biotechnology Announces $2.25M Private Placement Deal

Company Announcements

MAIA Biotechnology Announces $2.25M Private Placement Deal

7M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >